Schedule 13G ownership disclosure

C4 Therapeutics Inc

Common Stock · CUSIP: 12529R107

Event date: 2025-06-30

Filing-level shares
4,750,383
Percent of class
6.7%
  • Morgan Stanley

    Shares: 4,750,383 · Class: 6.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000489
Form type
SCHEDULE 13G/A
Filer
C4 Therapeutics, Inc.
CIK
CIK 1662579
Filed
Aug 07, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub